Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid ArthritisRheumatology and Therapy - Tập 4 - Trang 405-417 - 2017
Leslie R. Harrold, Ani John, George W. Reed, Tmirah Haselkorn, Chitra Karki, YouFu Li, Jennie Best, Steve Zlotnick, Joel M. Kremer, Jeffrey D. Greenberg
Tocilizumab (TCZ) monotherapy has been proven as an effective treatment for
rheumatoid arthritis (RA) in clinical trials. However, there are limited data
available regarding the effectiveness of TCZ monotherapy in real-world clinical
settings in the United States. The objective of this study was to evaluate the
impact of TCZ monotherapy on disease activity and patient-reported outcomes
(PROs) in a... hiện toàn bộ
Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 StudyRheumatology and Therapy - Tập 4 - Trang 475-488 - 2017
Hasan Tahir, Atul Deodhar, Mark Genovese, Tsutomu Takeuchi, Jacob Aelion, Filip Van den Bosch, Sibylle Haemmerle, Hanno B. Richards
‘REASSURE’ (NCT01377012), a phase 3 study, evaluated the efficacy and safety of
secukinumab in patients with active rheumatoid arthritis (RA) who had an
inadequate response to, or intolerance of, tumor necrosis factor inhibitors
(TNF-inhibitors). A total of 637 patients were randomized (1:1:1) to receive
intravenous secukinumab 10 mg/kg (baseline, weeks 2 and 4) followed by
subcutaneous secukinuma... hiện toàn bộ
Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO CohortRheumatology and Therapy - Tập 10 - Trang 225-238 - 2022
Sara Baydoun, Sandrine Jousse-Joulin, Alain Saraux, Perrine Dusser-Benesty, Charlotte Borocco, Caroline Galeotti, Annette Von Scheven, Michael Hofer, Brigitte Bader-Meunier, Florence Aeschlimann, Sylvain Breton, Laetitia Sparsa, Aurélia Carbasse, Gaël Mouterde, Linda Rossi-Semerano, Valérie Devauchelle-Pensec
The treatment of children with juvenile idiopathic arthritis (JIA) to prevent
disability is a major challenge in paediatric rheumatology. The presence of
synovitis, which is difficult to detect in children, is associated with
structural damage. Musculoskeletal ultrasonography (MSUS) can be used in
patients with JIA to reveal subclinical synovitis. The primary aim was to
determine whether the use o... hiện toàn bộ
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RARheumatology and Therapy - Tập 9 - Trang 465-480 - 2021
Leslie R. Harrold, Sean E. Connolly, Keith Wittstock, Joe Zhuo, Sheila Kelly, Thomas Lehman, Ying Shan, Sabrina Rebello, Lin Guo, Vadim Khaychuk
Patients with rheumatoid arthritis (RA) may respond to treatments differently
based on their underlying serology and biomarker status, but real-world data
comparing treatment responses to abatacept versus other non-TNFi biologic or
targeted-synthetic DMARDs by anti-citrullinated protein antibody (ACPA) status
remain limited. We assessed the association between ACPA status and response to
treatment... hiện toàn bộ
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic StudyRheumatology and Therapy - - 2024
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J. Gómara, Ana Belén Azuaga, Juan C. Sarmiento-Monroy, Rosa Morlà, Virginia Ruiz-Esquide, Laura Macías, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D. Cañete, Jordi Yague, Josep M. Auge, José A. Gomez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmarti
This study assesses the accuracy of neutrophil activation markers, including
neutrophil extracellular traps (NETs) and calprotectin, as biomarkers of disease
activity in patients with established rheumatoid arthritis (RA). We also analyse
the relationship between NETs and various types of therapies as well as their
association with autoimmunity. Observational cross-sectional study of patients
with... hiện toàn bộ
Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future NeedsRheumatology and Therapy - Tập 3 - Trang 43-51 - 2016
Ilse Degreef
Dupuytren disease is highly prevalent and the finger contractures can be very
extensile, compromising the patients’ hand function. To restore full function,
contractures have been addressed by cutting the causative strands for nearly
200 years, ever since Baron Guillaume Dupuytren demonstrated his technique at
the beginning of the nineteenth century. Surgery can be minimal (fasciotomy) or
quite in... hiện toàn bộ
Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing PhenotypeRheumatology and Therapy - Tập 5 - Trang 311-316 - 2018
Antonio Marchesoni
Details continue to emerge on psoriatic arthritis, expanding our understanding
of its pathogenesis and clinical features. This has led to the evolution of
management guidelines, which now recognize additional disease manifestations. In
this rapidly changing area, it is timely to review the latest evidence and
discuss whether management strategies are meeting patients’ needs. Celgene
Corporation.
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development ProgramsRheumatology and Therapy - Tập 10 - Trang 357-373 - 2022
Kevin L. Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal, Maria Galindo, John C. Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B. Shapiro, Thomas V. Jones, Annette Diehl, Chinyu Su, Julian Panés, Stanley B. Cohen
This post hoc analysis evaluated influenza adverse events (AEs) across
rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic arthritis
(PsA) tofacitinib clinical programs. Available data from phase 1, randomized
phase 2/3/3b/4 clinical trials (completed by 2018), and long-term extension
(LTE) studies (up to May 2019) in patients with RA, UC, and PsA were included
[randomized or Overall... hiện toàn bộ
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical PracticeRheumatology and Therapy - Tập 6 - Trang 421-433 - 2019
Dimitrios A. Pappas, Carol J. Etzel, Steve Zlotnick, Jennie Best, Taylor Blachley, Joel M. Kremer
Prednisone is frequently administered in combination with other therapies for
the treatment of rheumatoid arthritis (RA); however, its chronic use is
associated with an increased risk of comorbidities and mortality. The objective
of this analysis was to evaluate changes in prednisone use among patients with
RA treated with tocilizumab (TCZ) in routine US clinical practice. TCZ-naïve
patients in th... hiện toàn bộ